Determination of Δ9-tetrahydrocannabinol in pharmaceutical vehicles by high-performance liquid chromatography vehicles by high-performance liquid chromatography
- 1 February 1981
- journal article
- research article
- Published by Elsevier in Journal of Chromatography A
- Vol. 206 (1) , 117-123
- https://doi.org/10.1016/s0021-9673(00)82611-4
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Δ9-Tetrahydrocannabinol for Refractory Vomiting Induced by Cancer ChemotherapyJAMA, 1980
- Antiemetics in Patients Receiving Chemotherapy for CancerNew England Journal of Medicine, 1980
- Delta-9-Tetrahydrocannabinol as an Antiemetic for Patients Receiving Cancer ChemotherapyAnnals of Internal Medicine, 1979
- Delta-9-Tetrahydrocannabinol as an Antiemetic in Cancer Patients Receiving High-Dose MethotrexateAnnals of Internal Medicine, 1979
- The Separation, Identification, and Quantitation of Cannabinoids and Their t-Butyldimethylsilyl, Trimethylsilylacetate, and Diethylphosphate Derivatives Using High-Pressure Liquid Chromatography, Gas-Liquid Chromatography, and Mass SpectrometryJournal of Chromatographic Science, 1976
- The stability of cannabis and its preparations on storageJournal of Pharmacy and Pharmacology, 1976
- Antiemetic Effect of Delta-9-Tetrahydrocannabinol in Patients Receiving Cancer ChemotherapyNew England Journal of Medicine, 1975
- Physicochemical Properties, Solubility, and Protein Binding of Δ9 -TetrahydrocannabinolJournal of Pharmaceutical Sciences, 1974
- An intravenous formulation of Δ9-tetrahydrocannabinol using a non-ionic surfactantJournal of Pharmacy and Pharmacology, 1973
- Hashish VI1: Conversion of (-)-Δ 1(6)-Tetrahydrocannabinol to (-)-Δ 1(7)-Tetrahydrocannabinol. Stability of (-)-Δ 1 and (-)-Δ 1(6)-TetrahydrocannabinolsCellular and Molecular Life Sciences, 1972